Skip to Content

Join the 'Vioxx' group to help and get support from people like you.

Vioxx News

Common Painkillers Tied to Slight Rise in Heart Attack Risk

Posted 10 May 2017 by

TUESDAY, May 9, 2017 – Commonly used painkillers such as Motrin, Advil and Aleve might increase your risk for heart attack, even in the first week of use, a new study suggests. Overall, these drugs and others known as nonsteroidal anti-inflammatory drugs (NSAIDs) increase the risk of a heart attack by 20 to 50 percent, compared with not using them, researchers found. For most people, however, ...

Celebrex May Not Pose Bigger Heart Risk Than Similar Drugs: Study

Posted 14 Nov 2016 by

MONDAY, Nov. 14, 2016 – Some people taking the pain reliever Celebrex may not have a greater risk for heart problems than those taking other nonsteroidal anti-inflammatory drugs (NSAIDs), a new study says. Celebrex (celecoxib) is a COX-2 inhibitor. That's the same class of drugs as Vioxx and Bextra, which were pulled from the market in 2004 and 2005, respectively, because they were linked to ...

Giving the 'Green Light' to Migraine Relief

Posted 17 May 2016 by

TUESDAY, May 17, 2016 – A new study sheds light – literally – on a potential means of easing migraine pain. Researchers in Boston exposed 69 migraine patients to different colors of light. They found that while blue light exacerbated headache pain, a narrow spectrum of low-intensity green light significantly reduced light sensitivity. In some cases, this green light also reduced migraine pain ...

X-Rays May Miss Hip Arthritis, Study Finds

Posted 10 Dec 2015 by

THURSDAY, Dec. 10, 2015 – X-rays don't detect hip arthritis in many patients, resulting in delayed diagnosis and treatment, researchers report. The researchers looked at information from almost 4,500 Americans taking part in two arthritis studies. In one study, only 16 percent of patients with hip pain had X-ray evidence of osteoarthritis in the hip and only 21 percent of those with X-ray ...

Certain Painkillers Tied to Raised Risk of Death After Stroke

Posted 5 Nov 2014 by

WEDNESDAY, Nov. 5, 2014 – Arthritis pain relievers known as COX-2 inhibitors, including Celebrex and Lodine, are associated with an increased risk of dying within a month after a stroke, according to a new study. "This large study from Denmark adds to the prior concerns about COX-2 inhibitors and stroke risks," said Dr. Ralph Sacco, chairman of neurology at the University of Miami Miller School ...

Common Painkillers Tied to Blood Clot Risk, Study Suggests

Posted 24 Sep 2014 by

WEDNESDAY, Sept. 24, 2014 – People who use painkillers called nonsteroidal anti-inflammatory drugs (NSAIDs) – which include aspirin, naproxen (Aleve) and ibuprofen (Advil, Motrin) – may be at increased risk for potentially deadly blood clots, a new study suggests. But the study only showed an association between use of the painkillers and higher clotting risk; it did not prove ...

Common Painkillers May Help Prevent Skin Cancer: Study

Posted 29 May 2012 by

TUESDAY, May 29 – Taking nonsteroidal anti-inflammatory drugs (NSAIDs) – which include medicine cabinet staples such as aspirin, Motrin and Aleve – appears to significantly lower the risk for developing several major forms of skin cancer, a new Danish study reveals. What's more, the apparent protective impact of both prescription and nonprescription NSAIDs on skin cancer risk seems to be ...

Scientists Spot How Cox-2 Painkillers Raise Heart Risks

Posted 2 May 2012 by

WEDNESDAY, May 2 – New research has uncovered how some cox-2 painkillers increase the risk for both heart attacks and stroke. The once popular cox-2 drugs, Vioxx and Bextra, were pulled off the market in 2004 and 2005, respectively, after research showed that both raised the chances of cardiovascular trouble. Meanwhile, Celebrex, a painkiller in the same drug class that remains on the market, ...

Better Ways Needed to Track Drug Safety: Report

Posted 1 May 2012 by

TUESDAY, May 1 – A management plan to gather, assess and respond to data about all medications' risks from the time they are approved until they are no longer on the market is needed to improve drug safety in the United States, says an Institute of Medicine report released Tuesday. The U.S. Food and Drug Administration approves new drugs based on clinical trial evidence that their benefits ...

Merck to Pay $950M to Settle Probe of Vioxx Marketing

Posted 23 Nov 2011 by

TUESDAY, Nov. 22 – The U.S. Justice Department said Tuesday that the drug company Merck will pay $950 million to resolve investigations into its marketing of the blockbuster painkiller Vioxx, which was pulled from the market in 2004 after studies revealed the drug increased users' risks of heart attack and stroke. Merck will pay $321.6 million in criminal fines and $628.4 million as a civil ...

Some Pain Meds Riskier for Cardiac Patients Than Others, Study Suggests

Posted 28 Sep 2011 by

From Canadian Press DataFile (September 27, 2011) By Helen Branswell TORONTO – A new study suggests some commonly consumed pain medications are riskier than others when used by people with cardiovascular problems. The research suggests a couple of the drugs carry the same level of risk as Vioxx, which was taken off the market in 2004 over heart health concerns. Senior author Dr. David Henry says ...

Painkillers May Raise Risk of Dangerous Heart Flutter

Posted 5 Jul 2011 by

TUESDAY, July 5 – A new study finds that painkillers widely used to treat inflammation are associated with an increased risk of atrial fibrillation, a heart rhythm disorder connected with a raised risk of stroke, heart failure and death. Previous research has linked non-steroidal anti-inflammatory drugs (NSAIDs) and newer anti-inflammatory medications known as cox-2 inhibitors to an increased ...

Certain Painkillers Appear to Boost Odds for Heart Attack

Posted 11 Jan 2011 by

TUESDAY, Jan. 11 – Common painkillers taken to treat inflammation, such as Celebrex and Advil, can raise the risk of heart attack, stroke or death, a review of existing research suggests. Swiss researchers analyzed the results of 31 trials involving seven non-steroidal anti-inflammatory drugs (NSAIDs), as these medications are called, and concluded that cardiovascular risk needs to be considered ...

Vioxx Problems Known Years Before Recall

Posted 1 Dec 2009 by

MONDAY, Nov. 23 – Problems with the popular arthritis drug Vioxx, including increased risk for heart attack, stroke and death, were known for years before the drug's voluntary withdrawal from the market in 2004, a new report says. Contrary to claims by the manufacturer, Merck & Co., dangerous side effects were evident in 2000, a year after the drug was put on sale, but independent investigators ...

FDA Medwatch Alert: Vioxx (rofecoxib) - Apr 7, 2005

Posted 7 Apr 2005 by

After concluding that the overall risk versus benefit profile is unfavorable, FDA has requested Pfizer, Inc. to voluntarily withdraw Bextra (valdecoxib) from the market. This request is based on: * The lack of adequate data on the cardiovascular safety of long-term use of Bextra, along with the increased risk of adverse cardiovascular (CV) events in short-term coronary artery bypass surgery ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Period Pain, Dysmenorrhea, Migraine, Pain, Rheumatoid Arthritis, Osteoarthritis

Vioxx Patient Information at